RESEARCH ARTICLE
CAN AN M-HEALTH APPLICATION IMPROVE THE BLOOD PRESSURE CONTROL IN NEWLY DIAGNOSED PATIENTS WITH ARTERIAL HYPERTENSION?

UDK: 616.12-008.331.1-084

Janevska S¹, Godjoski A², Gerasimovska B³, Kovachevikj K¹, Ristoska K4

 

¹ PHO “Vita Katerina”, Skopje, Republic of North Macedonia

²“Angor AG”, Struga, Republic of North Macedonia

³ University Clinic for Nephrology, Skopje, Republic of N Macedonia

⁴”Zan Mitrev Clinic”, Skopje, Republic of North Macedonia

 

Abstract

Introduction.Hypertension is a leading cause of overall morbidity and mortality worldwide. The use of telemonitoring opens new opportunities for close monitoring of patients with hypertension through self-monitoring of blood pressure at home and timely transfer of these to primary care physicians.

Objective. To assess the effect of using an mHealth application in improving blood pressure control in patients with newly diagnosed hypertension.

Methods and materials.Results from the first 6 months of a prospective randomized controlled multicenter trial with 12-months follow-up of newly diagnosed patients with hypertension. The intervention group received standard care + mHealth app, while the control group received standard care alone. The study monitored ambulatory blood pressure measurements at 0, 1, 3, 6 and 12 months.

Results.95 participants in the intervention group and 97 in control group were recruited. In terms of systolic blood pressure values after 6 months, a decrease in the average systolic blood pressure was observed in both groups, with a decrease in the average by 22mmHg in the intervention, i.e. 20mmHg in the control group with a difference of 2mmHg in favor of the intervention group. A reduction in the average diastolic bood pressure of 13.4mmHg occurred in the intervention, i.e. 12.75mmHg in the standard care group, with a difference of 0.65mmHg in favor of the intervention group.

Conclusion.An mHealth application that enables two-way patient-physician communication is an auxiliary tool to standard care that may improve blood pressure control in newly diagnosed patients with hypertension.

Key Words: Family doctor; hypertension; mHealth application; self-monitoring.

Refferences:

  1. Banegas JR, Lopez-Garcia E, Dallongeville J, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011;32:2143–2152.
  2. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959–968.
  3. World Health Organization. Health Topics: Hypertension. 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/hypertension. Last assessed 16.03.2023.
  4. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017;389(10064):37-55. doi:10.1016/S0140-6736(16)31919-5.
  5. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223.
  6. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.
  7. World Health Organization. North Macedonia. Hypertension profiles, 2023 [document on the internet]. Available from: https://cdn.who.int/media/docs/default-source/country-profiles/hypertension/hypertension-2023/hypertension_mkd_2023.pdf?sfvrsn=20762a16_4&download=true.
  8. Brunström M, Carlberg B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(1):28-36. doi:10.1001/jamainternmed.2017.6015.
  9. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.
  10. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3104. doi:10.1093/eurheartj/ehy339.
  11. Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood pressure control. N Engl J Med. 2015;373:2103–2116.
  12. Upadhya B, Rocco M, Lewis CE, et al. Effect of intensive blood pressure treatment on heart failure events in the systolic blood pressure reduction intervention trial. Circ Heart Fail. 2017;10:e003613.
  13. Sobieraj P, Lewandowski J, Siński M, et al. Low on-treatment diastolic blood pressure and cardiovascular outcome: a post-hoc analysis using NHLBI SPRINT research materials. Sci Rep. 2019;9(1):13070.
  14. McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912-4018. doi:10.1093/eurheartj/ehae178.